Casdin Capital, LLC: holdings and changes
Number 47 of the top 100 funds by copy return. Casdin Capital, LLC reported 48 US stocks worth $2.3B for the quarter ending 2026-09-30 and changed 7 new, 7 added, 5 trimmed and 2 sold since 2026-06-30.
Copy return, 4 quarters+47.7%
US 500, same time+14.5%
Size$2.3B
Stocks48
Holdings
| Stock | Change | Weight | Value | Shares |
|---|---|---|---|---|
| RVMD Revolution Medicines INC | 23.04% | $529M | 2,577,333 | |
| RLAY Relay Therapeutics INC | 12.61% | $289M | 16,035,240 | |
| WGS Genedx Holdings | 11.68% | $268M | 3,707,164 | |
| BIOLIFE SOLUTI Biolife Solutions INC | TRIM -3% | 7.62% | $175M | 4,500,000 |
| ILMN Illumina | 6.32% | $145M | 530,000 | |
| GRAL Grail INC | ADD +42% | 4.15% | $95M | 680,000 |
| TXG 10x Genomics INC-Class A | 4.13% | $95M | 1,050,000 | |
| Fluidigm Corp Fluidigm Corp | 2.86% | $66M | 88,783,856 | |
| NGNE Neurogene INC Com | 1.92% | $44M | 1,585,361 | |
| SRRK Scholar Rock Hldg Corp | ADD +28% | 1.79% | $41M | 850,000 |
| PSNL Personalis INC | TRIM -10% | 1.63% | $37M | 2,300,000 |
| BEAM Beam Therapeutics INC | ADD +11% | 1.60% | $37M | 1,500,000 |
| TEM Tempus AI INC. Cl A | BUY | 1.51% | $35M | 423,597 |
| SRPT Sarepta Therapeutics INC | ADD +287% | 1.44% | $33M | 1,820,000 |
| GH Guardant Health INC | 1.44% | $33M | 185,000 | |
| GPCR Structure Therapeutics INC | TRIM -12% | 1.40% | $32M | 1,030,000 |
| ALNY Alnylam Pharmaceuticals INC | ADD +60% | 1.29% | $30M | 120,000 |
| DNLI Denali Therapeutics INC | TRIM -39% | 1.13% | $26M | 1,250,000 |
| HIMS Hims & Hers Heal | ADD +14% | 1.04% | $24M | 800,000 |
| MAZE Maze Therapeutics | 1.00% | $23M | 843,857 | |
| SEPN Septerna INC | 0.94% | $22M | 553,268 | |
| PBLS Parabilis Medicines, INC. | 0.91% | $21M | 645,690 | |
| ANL Adlai Nortye LTD | 0.87% | $20M | 1,250,000 | |
| TSHA Taysha Gene Therapies INC Com Shs | ADD +20% | 0.83% | $19M | 3,900,000 |
| AGMB Agomab Therapeutics Nv | 0.75% | $17M | 1,550,000 | |
| ORIC Oric Pharmaceuticals INC | BUY | 0.73% | $17M | 1,250,000 |
| MRNA Moderna INC | 0.63% | $14M | 75,000 | |
| VCYT Veracyte INC | 0.55% | $13M | 276,308 | |
| DGX Quest Diagnostics INC Com | 0.51% | $12M | 50,000 | |
| Biogen Idec Biogen Idec | BUY | 0.49% | $11M | 50,000 |
| EWTX Edgewise Therapeutics INC | BUY | 0.47% | $11M | 265,000 |
| ABSI Absci Corporation | 0.46% | $10M | 973,260 | |
| PRME Prime Medicine INC | 0.42% | $10M | 3,167,175 | |
| BNTX Biontech Se | BUY | 0.36% | $8M | 85,000 |
| BRVE Braveheart Bio INC | BUY | 0.35% | $8M | 400,000 |
| RAPP Rapport Therapeutics INC | BUY | 0.29% | $7M | 200,000 |
| NTLA Intellia Therapeutics INC | 0.19% | $4M | 355,000 | |
| QURE Uniqure Nv | 0.16% | $4M | 150,000 | |
| IPSC Century Therapeutics INC | 0.09% | $2M | 1,228,190 | |
| CTNM Contineum Therapeutics INC | 0.09% | $2M | 148,333 | |
| PACB Pacific Biosciences Calif In | 0.07% | $2M | 723,767 | |
| BBOT Bridgebio Oncology Therapeutics Ord | 0.05% | $1M | 282,312 | |
| EDIT Editas Medicine INC | 0.05% | $1M | 445,000 | |
| GLUE Monte Rosa Therapeutics INC | TRIM -54% | 0.04% | $1M | 86,014 |
| KARD Kardigan INC | 0.03% | $700k | 50,000 | |
| RXRX Recursion Pharmaceuticals INC | 0.03% | $700k | 165,323 | |
| DNA Ginkgo Bioworks Holdings INC | 0.02% | $500k | 36,493 | |
| TNYA Tenaya Therapeutics INC Com | 0.01% | $200k | 361,969 | |
| SION Sionna Therapeutics INC | SELL | 0% | was $18M | 0 |
| IRON Disc Medicine INC | SELL | 0% | was $5M | 0 |
Copy return each quarter
| Held | Fund copy | US 500 |
|---|---|---|
| 2023-09-30 → 2023-12-31 | +12.9% | +11.2% |
| 2023-12-31 → 2024-03-31 | +12.5% | +10.0% |
| 2024-03-31 → 2024-06-30 | -0.5% | +4.0% |
| 2024-06-30 → 2024-09-30 | +8.1% | +5.4% |
| 2024-09-30 → 2024-12-31 | -5.4% | +2.1% |
| 2024-12-31 → 2025-03-31 | -20.5% | -4.6% |
| 2025-03-31 → 2025-06-30 | +3.2% | +10.5% |
| 2025-06-30 → 2025-09-30 | +22.9% | +7.8% |
| 2025-09-30 → 2025-12-31 | +25.5% | +2.4% |
| 2025-12-31 → 2026-03-31 | -21.7% | -4.6% |
| 2026-03-31 → 2026-06-30 | +36.6% | +14.8% |
| 2026-06-30 → 2026-09-30 | +10.0% | +2.1% |
The copy return buys the fund's reported stocks on the day after the filing became public and holds them for one quarter, so it measures what anyone reading the filings could have done.
All top 100 funds, liveOther top funds
Nextech Invest LTD.Venrock Adviser, LLCFairmount Funds Management LLCTalos Eurisko Asset Management LPAnalog Century Management LPQvt Financial LPBroad Peak Investment Advisers Pte LTDWs Management LllpBvf INC/IlParadigm Biocapital Advisors LPOak Grove Capital LLCCm Wealth Advisors LLCAvidity Partners Management LPFirst Light Asset Management, LLCLogos Global Management LPSummit Street Capital Management, LLCMadison Avenue Partners, LPDivisar Capital Management LLCTcg Crossover Management, LLCOptimus Prime Fund Management Co., LTD.Value Aligned Research Advisors, LLCBraidwell LPRedmile Group, LLCOrbimed Advisors LLCMpm Bioimpact LLCCloudalpha Capital Management Limited/Hong KongGeneral Pension Society Pzu Joint Stock CoAmanah Holdings TrustSlate Path Capital LPDeep Track Capital, LP